LY96 and cancer: LY96 is related to DNA methylation, copy number, microsatellite instability (MSI), somatic mutation, tumor mutation burden (TMB), tumor microenvironment (TME) features and immune cell infiltration in cancers, and LY96 can contribute to drug resistance and regulate classic tumor-associated pathways (Nie et al., 2022).